201 related articles for article (PubMed ID: 34952899)
21. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
[TBL] [Abstract][Full Text] [Related]
22. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice.
Oladunni FS; Park JG; Pino PA; Gonzalez O; Akhter A; Allué-Guardia A; Olmo-Fontánez A; Gautam S; Garcia-Vilanova A; Ye C; Chiem K; Headley C; Dwivedi V; Parodi LM; Alfson KJ; Staples HM; Schami A; Garcia JI; Whigham A; Platt RN; Gazi M; Martinez J; Chuba C; Earley S; Rodriguez OH; Mdaki SD; Kavelish KN; Escalona R; Hallam CRA; Christie C; Patterson JL; Anderson TJC; Carrion R; Dick EJ; Hall-Ursone S; Schlesinger LS; Alvarez X; Kaushal D; Giavedoni LD; Turner J; Martinez-Sobrido L; Torrelles JB
Nat Commun; 2020 Nov; 11(1):6122. PubMed ID: 33257679
[TBL] [Abstract][Full Text] [Related]
23. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
24. Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection.
Tamir H; Melamed S; Erez N; Politi B; Yahalom-Ronen Y; Achdout H; Lazar S; Gutman H; Avraham R; Weiss S; Paran N; Israely T
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215785
[TBL] [Abstract][Full Text] [Related]
25. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
26. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z
Front Immunol; 2020; 11():621441. PubMed ID: 33584719
[TBL] [Abstract][Full Text] [Related]
27. Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19-related Acute Respiratory Distress Syndrome.
Gerard L; Lecocq M; Bouzin C; Hoton D; Schmit G; Pereira JP; Montiel V; Plante-Bordeneuve T; Laterre PF; Pilette C
Am J Respir Crit Care Med; 2021 Nov; 204(9):1024-1034. PubMed ID: 34449302
[No Abstract] [Full Text] [Related]
28. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
Juanes-Velasco P; Landeira-Viñuela A; García-Vaquero ML; Lecrevisse Q; Herrero R; Ferruelo A; Góngora R; Corrales F; Rivas JL; Lorente JA; Hernández ÁP; Fuentes M
Front Immunol; 2022; 13():732197. PubMed ID: 35154090
[TBL] [Abstract][Full Text] [Related]
30. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease.
Golden JW; Cline CR; Zeng X; Garrison AR; Carey BD; Mucker EM; White LE; Shamblin JD; Brocato RL; Liu J; Babka AM; Rauch HB; Smith JM; Hollidge BS; Fitzpatrick C; Badger CV; Hooper JW
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32841215
[TBL] [Abstract][Full Text] [Related]
31. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
[TBL] [Abstract][Full Text] [Related]
32. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
[TBL] [Abstract][Full Text] [Related]
33. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
[TBL] [Abstract][Full Text] [Related]
34. The COVID-19 pandemic: a global health crisis.
Pollard CA; Morran MP; Nestor-Kalinoski AL
Physiol Genomics; 2020 Nov; 52(11):549-557. PubMed ID: 32991251
[TBL] [Abstract][Full Text] [Related]
35. Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route.
Pan T; Chen R; He X; Yuan Y; Deng X; Li R; Yan H; Yan S; Liu J; Zhang Y; Zhang X; Yu F; Zhou M; Ke C; Ma X; Zhang H
Signal Transduct Target Ther; 2021 Dec; 6(1):420. PubMed ID: 34907154
[TBL] [Abstract][Full Text] [Related]
36. Natural Killer Cells Do Not Attenuate a Mouse-Adapted SARS-CoV-2-Induced Disease in
Ellsworth CR; Wang C; Katz AR; Chen Z; Islamuddin M; Yang H; Scheuermann SE; Goff KA; Maness NJ; Blair RV; Kolls JK; Qin X
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675952
[TBL] [Abstract][Full Text] [Related]
37. Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice.
Asaka MN; Utsumi D; Kamada H; Nagata S; Nakachi Y; Yamaguchi T; Kawaoka Y; Kuba K; Yasutomi Y
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34463644
[TBL] [Abstract][Full Text] [Related]
38. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
[TBL] [Abstract][Full Text] [Related]
39. Animal models for SARS-Cov2/Covid19 research-A commentary.
Jarnagin K; Alvarez O; Shresta S; Webb DR
Biochem Pharmacol; 2021 Jun; 188():114543. PubMed ID: 33812856
[TBL] [Abstract][Full Text] [Related]
40. H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice.
Li H; Zhao X; Zhao Y; Li J; Zheng H; Xue M; Guo L; Zhou J; Yang J; Zuo Y; Chen Y; Yang Z; Fan Q; Qin L; Shi H; Liu L
Emerg Microbes Infect; 2021 Dec; 10(1):1156-1168. PubMed ID: 34060982
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
